Riskpilot← Back to searchSign inGet full accessBluegreen Holding AB
ABActiveOrg 5591834691Economic activity was not specified by tax authority · NACE 0000Est. 20180 employees
Revenue 2025
SEK 0
EBITDA margin
—
+86% vs 2024
Equity ratio
90.3%
Financial strength
Net profit 2025
SEK 2,3M
+17% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -23K | +86% |
| Net profit | SEK 2,3M | +17% |
| Total assets | SEK 8,2M | +17% |
| Equity | SEK 7,4M | +27% |
| Employees | 0 | — |
Legal name
Bluegreen Holding AB
Org number
5591834691
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
4 december 2018
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska äga och förvalta aktier, värdepapper och fastigheter samt därmed förenlig verksamhet.
Address
Email
kim.hyllen@addvancepharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −13 | −13 | −28 | −170 | −23 |
| Depreciation & amort. | −0 | −0 | — | −0 | −0 |
| EBIT | −13 | −13 | −28 | −170 | −23 |
| Net financials | 600 | — | 9 | 1 296 | 1 828 |
| Profit before tax | 1 788 | 1 487 | 2 241 | 1 986 | 2 370 |
| Tax | −250 | −306 | −462 | −6 | −48 |
| Net profit | 1 538 | 1 181 | 1 779 | 1 980 | 2 322 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 447 | 3 833 | 5 965 | 6 995 | 8 168 |
| Equity | 3 197 | 3 277 | 4 456 | 5 787 | 7 373 |
| Long-term debt | 0 | 0 | — | 0 | 0 |
| Short-term debt | 250 | 556 | 769 | 469 | 55 |
| Total debt | 250 | 556 | 769 | 469 | 55 |
EBITDA margin
-2300000.0%
This company
15.8%
Market median
-14557062% vs market
20212025
Equity ratio
90.3%
This company
38.2%
Market median
+136% vs market
20212025
Return on equity
31.5%
This company
18.4%
Market median
+71% vs market
20212025
Net profit margin
232200000.0%
This company
8.1%
Market median
+2866666567% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MC Audit | Audit | 2022 |
| Former (1) | ||
HM Audit | Audit | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bluegreen Holding AB 
Addvance Pharma In Scandinavia ABBoard members of Bluegreen Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Christer Borg | Audit | 0 companies |
| Hanna Maria Ryttberg | Audit | 0 companies |
| Camilla Marianne Hyllén | Deputy Board Member | 0 companies |
| Kim Johan Hyllén | Board of Directors | 0 companies |